Inactive Instrument
Agile Therapeutics, Inc. Stock
Stocks
AGRX
US00847L3087
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Robert Spina
CEO | Chief Executive Officer | - | 2024-08-25 |
| Corporate Secretary | - | 2024-08-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Salustiano Pérez
CHM | Chairman | - | 2024-08-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/24 | Issuer sale | Director | 976 | 0.0142% | ||
| 8/26/24 | Issuer sale | Chief Administrative Officer | 20,256 | 0.2954% | ||
| 8/26/24 | Issuer sale | Chief Financial Officer | 20,080 | 0.2929% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.42% | - | - | 10.43M | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.38B | |
| +0.98% | +2.68% | +12.25% | +82.98% | 56.16B | |
| +1.75% | +2.01% | +13.30% | +103.69% | 54.16B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.33B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.25B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.78B | |
| -2.07% | +42.73% | +103.77% | +88.74% | 33.8B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -2.04% | -3.58% | +20.72% | -12.55% | 23.57B | |
| Average | -0.23% | +4.50% | +52.17% | +162.48% | 43.63B | |
| Weighted average by Cap. | -0.01% | +3.60% | +49.13% | +161.37% |
Employees
19
